Per- and polyfluoroalkyl substances and the risk of thyroid and breast cancer: Evidence from a meta-analysis and computational toxicology.

Toxicol Appl PharmacolJul 2, 2026 (epub)

Hao-Yang Shen, Meng-Hao Jin, Zi-Chao Wu et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis evaluated the association between per- and polyfluoroalkyl substances (PFAS) exposure and the risks of thyroid and breast cancer. The analysis included literature from January 2003 to May 2025. It found that perfluorooctanoic acid (PFOA) and perfluorohexane sulfonate (PFHxS) were inversely associated with thyroid cancer (OR 0.87 and 0.84, respectively), while overall PFAS exposure showed a borderline association with breast cancer (OR 1.04).

Key findings

  • PFOA exposure was associated with a thyroid cancer odds ratio of 0.87 (95% CI: 0.77-0.98).
  • PFHxS exposure was linked to a thyroid cancer odds ratio of 0.84 (95% CI: 0.75-0.94).
  • Overall PFAS exposure had an odds ratio of 1.04 (95% CI: 1.00-1.09) for breast cancer.
  • PFAS exposure was inversely associated with invasive breast cancer (OR = 0.45, 95% CI: 0.26-0.76).

Why it matters

Understanding the relationship between PFAS exposure and cancer risk is crucial for public health, as these substances are widespread environmental pollutants. This research may inform future studies and risk assessments regarding endocrine disruptors and cancer.

Source

Published in Toxicol Appl Pharmacol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Endocrinology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.